Skip to main content

Table 2 PEG-J replacement procedures: “pull” and “push” methods comparison

From: PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study

  “pull” n=41 “push” n=79
Clinical characteristicsb Mean range SD Mean range SD
 Age (years) 72.6 63-84 ± 7.0 73,2 63-84 ± 6.6
 Disease duration (years) 19.8 15-35 ± 5.7 18.6 12-35 ± 5.7
 Follow-up duration (months) 77.4 3-119 ± 4.4 64.9 15-119 ± 3.4
 MDS-UPDRS pt. III score 28.0 4-54 ± 2.3 34.4 10-66 ± 1.4
 mH&Y stage 2.9 2.5-4 ± 0.6 3.0 2.5-4 ± 0.5
 PEG-J duration (months) 7.7 0-27 ± 5.9 5.7 0-27 ± 4.9
Reason for replacementc n %   n %  
 Scheduled replacements 12 29.3   36 45.6  
 Stoma complicationsa 6 14.6   9 11.4  
 Unexpected replacements 29 70.7   43 54.4  
 Stoma complicationsa 13 31.7   11 13.9  
 Device related replacements 28    45   
 Patient related replacements 3    8   
Total 31 75   53 67